Suppr超能文献

14q32 微 RNA 簇中的变异与西班牙人群的骨肉瘤风险相关。

Variants in the 14q32 miRNA cluster are associated with osteosarcoma risk in the Spanish population.

机构信息

Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Science and Technology, University of the Basque Country, UPV/EHU, Leioa, Spain.

Department of Genetics, Physical Anthropology and Animal Physiology, Faculty of Medicine and Nursery, UPV/EHU, Leioa, Spain.

出版信息

Sci Rep. 2018 Oct 18;8(1):15414. doi: 10.1038/s41598-018-33712-4.

Abstract

Association studies in osteosarcoma risk found significant results in intergenic regions, suggesting that regions which do not codify for proteins could play an important role. The deregulation of microRNAs (miRNAs) has been already associated with osteosarcoma. Consequently, genetic variants affecting miRNA function could be associated with risk. This study aimed to evaluate the involvement of all genetic variants in pre-miRNAs described so far in relationship to the risk of osteosarcoma. We analyzed a total of 213 genetic variants in 206 pre-miRNAs in two cohorts of osteosarcoma patients (n = 100) and their corresponding controls (n = 256) from Spanish and Slovenian populations, using Goldengate Veracode technology (Illumina). Four polymorphisms in pre-miRNAs at 14q32 miRNA cluster were associated with osteosarcoma risk in the Spanish population (rs12894467, rs61992671, rs58834075 and rs12879262). Pathway enrichment analysis including target genes of these miRNAs pointed out the WNT signaling pathways overrepresented. Moreover, different single nucleotide polymorphism (SNP) effects between the two populations included were observed, suggesting the existence of population differences. In conclusion, 14q32 miRNA cluster seems to be a hotspot for osteosarcoma susceptibility in the Spanish population, but not in the Slovenian, which supports the idea of the existence of population differences in developing this disease.

摘要

骨肉瘤风险的关联研究在基因间区域发现了显著的结果,表明不编码蛋白质的区域可能发挥重要作用。microRNAs(miRNAs)的失调已与骨肉瘤相关。因此,影响 miRNA 功能的遗传变异可能与风险相关。本研究旨在评估迄今为止与骨肉瘤风险相关的所有 pre-miRNA 中的遗传变异的参与情况。我们使用 Goldengate Veracode 技术(Illumina),在来自西班牙和斯洛文尼亚人群的两个骨肉瘤患者队列(n=100)及其相应的对照者(n=256)中分析了总共 206 个 pre-miRNA 中的 213 个遗传变异。在西班牙人群中,14q32 miRNA 簇中的 4 个 pre-miRNA 多态性与骨肉瘤风险相关(rs12894467、rs61992671、rs58834075 和 rs12879262)。包括这些 miRNA 靶基因的通路富集分析指出,WNT 信号通路过度表达。此外,还观察到了两个人群之间不同的单核苷酸多态性(SNP)效应,表明存在人群差异。总之,14q32 miRNA 簇似乎是西班牙人群骨肉瘤易感性的热点,但在斯洛文尼亚人群中并非如此,这支持了在发生这种疾病方面存在人群差异的观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fccc/6194014/25e6c8c19130/41598_2018_33712_Fig1_HTML.jpg

相似文献

3
Polymorphisms in miRNA processing genes and their role in osteosarcoma risk.
Pediatr Blood Cancer. 2015 May;62(5):766-9. doi: 10.1002/pbc.25416. Epub 2015 Feb 7.
4
Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma.
Bone. 2012 Jan;50(1):171-81. doi: 10.1016/j.bone.2011.10.012. Epub 2011 Oct 18.
5
MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma.
Orphanet J Rare Dis. 2013 Jan 11;8:7. doi: 10.1186/1750-1172-8-7.
7
A MicroRNA cluster at 14q32 drives aggressive lung adenocarcinoma.
Clin Cancer Res. 2014 Jun 15;20(12):3107-17. doi: 10.1158/1078-0432.CCR-13-3348. Epub 2014 May 15.
10
Cytotoxic T lymphocyte-associated antigen 4 rs231775 polymorphism and osteosarcoma.
Neoplasma. 2017;64(2):299-304. doi: 10.4149/neo_2017_218.

引用本文的文献

1
Signatures of genetic variation in human microRNAs point to processes of positive selection and population-specific disease risks.
Hum Genet. 2022 Oct;141(10):1673-1693. doi: 10.1007/s00439-021-02423-8. Epub 2022 Mar 6.
2
MicroRNAs signatures, bioinformatics analysis of miRNAs, miRNA mimics and antagonists, and miRNA therapeutics in osteosarcoma.
Cancer Cell Int. 2020 Jun 17;20:254. doi: 10.1186/s12935-020-01342-4. eCollection 2020.
3
miR-328-3p mediates the anti-tumor effect in osteosarcoma via directly targeting MMP-16.
Cancer Cell Int. 2019 Apr 23;19:104. doi: 10.1186/s12935-019-0829-7. eCollection 2019.

本文引用的文献

1
Germline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy.
Nat Rev Endocrinol. 2017 Aug;13(8):480-491. doi: 10.1038/nrendo.2017.16. Epub 2017 Mar 24.
2
Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy.
J Hematol Oncol. 2017 Jan 7;10(1):10. doi: 10.1186/s13045-016-0373-z.
3
KEGG: new perspectives on genomes, pathways, diseases and drugs.
Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361. doi: 10.1093/nar/gkw1092. Epub 2016 Nov 28.
4
Single nucleotide polymorphism of hsa-miR-124a affects risk and prognosis of osteosarcoma.
Cancer Biomark. 2016 Jun 24;17(2):249-57. doi: 10.3233/CBM-160637.
6
The Reactome pathway Knowledgebase.
Nucleic Acids Res. 2016 Jan 4;44(D1):D481-7. doi: 10.1093/nar/gkv1351. Epub 2015 Dec 9.
7
Resveratrol inhibits canonical Wnt signaling in human MG-63 osteosarcoma cells.
Mol Med Rep. 2015 Nov;12(5):7221-6. doi: 10.3892/mmr.2015.4338. Epub 2015 Sep 21.
8
miRWalk2.0: a comprehensive atlas of microRNA-target interactions.
Nat Methods. 2015 Aug;12(8):697. doi: 10.1038/nmeth.3485.
9
Aberrant activation of Wnt/β-catenin signaling drives proliferation of bone sarcoma cells.
Oncotarget. 2015 Jul 10;6(19):17570-83. doi: 10.18632/oncotarget.4100.
10
Prognostic role of common microRNA polymorphisms in cancers: evidence from a meta-analysis.
PLoS One. 2014 Oct 22;9(10):e106799. doi: 10.1371/journal.pone.0106799. eCollection 2014.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验